ANN ARBOR — For the second consecutive year, patent attorney William R. Boudreaux has been named a “Life Sciences Star” by LMG Life Sciences, a guide for law firms and attorneys in life sciences.
A shareholder in the Ann Arbor office of Brinks Hofer Gilson & Lione, Boudreaux was selected for his expertise in the Intellectual Property Law category, which includes patent prosecution, patent strategy and management, and general patent litigation.
Boudreaux, of Ann Arbor, co-chairs Brinks’ biotechnology and pharmaceutical practice group and has specialized in patent law in the pharmaceutical and chemicals sectors since 1992. His practice includes client counseling for strategic patent portfolio development, global patent prosecution, IP diligence, and opinions for patentability, validity and freedom to operate.
Boudreaux has nearly 15 years as in-house counsel in the pharmaceutical industry, including at Pfizer and Eli Lilly. He has been primary patent counsel for several late-stage and post-launch drug products, including four blockbuster drugs, and has extensive experience in global patent portfolio creation, legal opinions, product life-cycle planning and IP diligence. His experience includes Hatch-Waxman litigation strategy and support, prosecution of patent reexamination and reissue applications, transactional work, appellate brief writing and international patent procurement and enforcement. Boudreaux represents a broad range of biotechnology and pharmaceutical clients, ranging from large companies to start-ups.
He received his J.D. from Louisiana State University Paul M. Hebert Law Center in Baton Rouge, and his bachelor’s in science in biiochemistry from Louisiana State University.
